{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T20:18:05Z","timestamp":1767212285788},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81522048","81573511","81273595","No.81503073"],"award-info":[{"award-number":["81522048","81573511","81273595","No.81503073"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The National High Technology Research and Development Program of China","award":["2012AA02A518","2012AA02A517"],"award-info":[{"award-number":["2012AA02A518","2012AA02A517"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.gene.2017.04.029","type":"journal-article","created":{"date-parts":[[2017,4,22]],"date-time":"2017-04-22T00:45:44Z","timestamp":1492821944000},"page":"63-71","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Effects of four novel genetic polymorphisms on clopidogrel efficacy in Chinese acute coronary syndromes patients"],"prefix":"10.1016","volume":"623","author":[{"given":"Fei-Yan","family":"Xiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bi-Lian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhao-Qian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Hao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gene.2017.04.029_bb0005","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3109\/09537104.2012.686072","article-title":"Clopidogrel plus indobufen in acute coronary syndrome patients with hypersensitivity to aspirin undergoing percutaneous coronary intervention","volume":"24","author":"Barilla","year":"2013","journal-title":"Platelets"},{"key":"10.1016\/j.gene.2017.04.029_bb0010","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.amjcard.2010.08.026","article-title":"Antiplatelet therapy in acute coronary syndrome (ACS): applying new science to clinical decisions","volume":"106","author":"Becker","year":"2010","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.gene.2017.04.029_bb0015","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.jacc.2010.04.047","article-title":"Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate","volume":"56","author":"Bonello","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.gene.2017.04.029_bb0020","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s11239-010-0457-5","article-title":"Poor response to clopidogrel: current and future options for its management","volume":"30","author":"Campo","year":"2010","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.gene.2017.04.029_bb0025","first-page":"9266","article-title":"Both PON1 Q192R and CYP2C19*2 influence platelet response to clopidogrel and ischemic events in Chinese patients undergoing percutaneous coronary intervention","volume":"8","author":"Chen","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.gene.2017.04.029_bb0030","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/cvr\/cvs007","article-title":"Microparticles: major transport vehicles for distinct microRNAs in circulation","volume":"93","author":"Diehl","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.gene.2017.04.029_bb0035","doi-asserted-by":"crossref","first-page":"14925","DOI":"10.1038\/srep14925","article-title":"Interaction between microRNA expression and classical risk factors in the risk of coronary heart disease","volume":"5","author":"Ding","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.gene.2017.04.029_bb0040","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1146\/annurev-biochem-060308-103103","article-title":"Regulation of mRNA translation and stability by microRNAs","volume":"79","author":"Fabian","year":"2010","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.gene.2017.04.029_bb0045","first-page":"893","article-title":"Analysis on the association of single nucleotide polymorphism in the promoter region of pre-miR-320b-2 with coronary heart disease risk and factors influencing circulating microRNA-320b level","volume":"48","author":"Feng","year":"2014","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"key":"10.1016\/j.gene.2017.04.029_bb0050","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/cns.12426","article-title":"Influence of genetic polymorphisms on clopidogrel response and clinical outcomes in patients with acute ischemic stroke CYP2C19 genotype on clopidogrel response","volume":"21","author":"Han","year":"2015","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.gene.2017.04.029_bb0055","first-page":"1","article-title":"CYP2C19 and CES1 polymorphisms and efficacy of clopidogrel and aspirin dual antiplatelet therapy in patients with symptomatic intracranial atherosclerotic disease","author":"Hoh","year":"2015","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.gene.2017.04.029_bb0060","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1177\/0091270011419852","article-title":"Clopidogrel pharmacodynamics and pharmacokinetics in the fed and fasted state: a randomized crossover study of healthy men","volume":"52","author":"Hurbin","year":"2012","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.gene.2017.04.029_bb0065","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.09.014","article-title":"CYP2C19 genotype and early ischemic lesion recurrence in stroke patients treated with clopidogrel","volume":"24","author":"Jeong","year":"2015","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.gene.2017.04.029_bb0070","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s40262-014-0230-6","article-title":"Clinical pharmacokinetics and pharmacodynamics of clopidogrel","volume":"54","author":"Jiang","year":"2015","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.gene.2017.04.029_bb0075","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2125.2011.04049.x","article-title":"Pharmacokinetics and pharmacodynamics following maintenance doses of prasugrel and clopidogrel in Chinese carriers of CYP2C19 variants","volume":"73","author":"Kelly","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.gene.2017.04.029_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/FPC.0b013e32835aa8a2","article-title":"The functional G143E variant of carboxylesterase 1 is associated with increased clopidogrel active metabolite levels and greater clopidogrel response","volume":"23","author":"Lewis","year":"2013","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.gene.2017.04.029_bb0085","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.4103\/0366-6999.162515","article-title":"CYP2C19*2 and other allelic variants affecting platelet response to clopidogrel tested by thrombelastography in patients with acute coronary syndrome","volume":"128","author":"Liu","year":"2015","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.gene.2017.04.029_bb0090","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1161\/CIR.0000000000000152","article-title":"Heart disease and stroke statistics\u20132015 update: a report from the American Heart Association","volume":"131","author":"Mozaffarian","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.gene.2017.04.029_bb0095","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1160\/TH14-11-0947","article-title":"Platelets, inflammation and anti-inflammatory effects of antiplatelet drugs in ACS and CAD","volume":"114","author":"Muller","year":"2015","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.gene.2017.04.029_bb0100","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11596-015-1404-7","article-title":"CYP2C19 polymorphism and clinical outcomes among patients of different races treated with clopidogrel: a systematic review and meta-analysis","volume":"35","author":"Niu","year":"2015","journal-title":"J. Huazhong Univ. Sci. Technolog. Med. Sci."},{"key":"10.1016\/j.gene.2017.04.029_bb0105","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejphar.2014.11.037","article-title":"Influence of CYP2C19 polymorphisms on platelet reactivity and clinical outcomes in ischemic stroke patients treated with clopidogrel","volume":"747","author":"Qiu","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.gene.2017.04.029_bb0110","doi-asserted-by":"crossref","first-page":"257","DOI":"10.6061\/clinics\/2015(04)07","article-title":"The diagnostic value of circulating microRNAs for middle-aged (40-60-year-old) coronary artery disease patients","volume":"70","author":"Sayed","year":"2015","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.gene.2017.04.029_bb0115","doi-asserted-by":"crossref","first-page":"e0145930","DOI":"10.1371\/journal.pone.0145930","article-title":"miRNA-197 and miRNA-223 predict cardiovascular death in a cohort of patients with symptomatic coronary artery disease","volume":"10","author":"Schulte","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.gene.2017.04.029_bb0120","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.amjcard.2005.01.049","article-title":"Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials","volume":"95","author":"Serebruany","year":"2005","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.gene.2017.04.029_bb0125","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jacc.2004.09.067","article-title":"Variability in platelet responsiveness to clopidogrel among 544 individuals","volume":"45","author":"Serebruany","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.gene.2017.04.029_bb0130","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1001\/jama.2009.1232","article-title":"Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy","volume":"302","author":"Shuldiner","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.gene.2017.04.029_bb0135","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ijcard.2016.02.129","article-title":"Impact of C34T P2Y12 ADP receptor polymorphism and smoking status on cardiovascular outcome in coronary artery disease patients receiving clopidogrel","volume":"210","author":"Siasos","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.gene.2017.04.029_bb0140","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1056\/NEJMra1210816","article-title":"Drug-eluting coronary-artery stents","volume":"368","author":"Stefanini","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.gene.2017.04.029_bb0145","doi-asserted-by":"crossref","first-page":"5434","DOI":"10.1002\/jps.21376","article-title":"Allosteric kinetics of human carboxylesterase 1: species differences and interindividual variability","volume":"97","author":"Takahashi","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.gene.2017.04.029_bb0150","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/cpt.101","article-title":"Carboxylesterase 1 c.428G>A single nucleotide variation increases the antiplatelet effects of clopidogrel by reducing its hydrolysis in humans","volume":"97","author":"Tarkiainen","year":"2015","journal-title":"Clin. Pharmacol. Ther."},{"issue":"Suppl. 1","key":"10.1016\/j.gene.2017.04.029_bb0155","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.2459\/JCM.0b013e328364bd25","article-title":"Identifying responsiveness to oral P2Y12 receptor blockers: platelet function assays and genetic tests","volume":"14","author":"Valgimigli","year":"2013","journal-title":"J. Cardiovasc. Med. (Hagerstown)"},{"key":"10.1016\/j.gene.2017.04.029_bb0160","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1093\/eurheartj\/ehq277","article-title":"Guidelines on myocardial revascularization","volume":"31","author":"Wijns","year":"2010","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.gene.2017.04.029_bb0165","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1016\/j.jacc.2011.02.009","volume":"57","author":"Wright","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.gene.2017.04.029_bb0170","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ijcard.2015.04.097","article-title":"CYP2C19 LOF alleles confer no risk for HTPR but higher risk for recurrent ischemic events in clopidogrel treated elderly ACS patients","volume":"189","author":"Yang","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.gene.2017.04.029_bb0175","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1093\/eurheartj\/ehu151","article-title":"Assessment of microRNAs in patients with unstable angina pectoris","volume":"35","author":"Zeller","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.gene.2017.04.029_bb0180","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.thromres.2014.12.007","article-title":"Effect of high-dose clopidogrel according to CYP2C19*2 genotype in patients undergoing percutaneous coronary intervention- a systematic review and meta-analysis","volume":"135","author":"Zhang","year":"2015","journal-title":"Thromb. Res."},{"key":"10.1016\/j.gene.2017.04.029_bb0185","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1124\/jpet.112.201640","article-title":"Carboxylesterase 1 as a determinant of clopidogrel metabolism and activation","volume":"344","author":"Zhu","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111917302809?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111917302809?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T09:53:37Z","timestamp":1535882017000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111917302809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":37,"alternative-id":["S0378111917302809"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2017.04.029","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of four novel genetic polymorphisms on clopidogrel efficacy in Chinese acute coronary syndromes patients","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2017.04.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}